545 related articles for article (PubMed ID: 18079394)
21. The crystal structure of Pyrococcus furiosus UMP kinase provides insight into catalysis and regulation in microbial pyrimidine nucleotide biosynthesis.
Marco-Marín C; Gil-Ortiz F; Rubio V
J Mol Biol; 2005 Sep; 352(2):438-54. PubMed ID: 16095620
[TBL] [Abstract][Full Text] [Related]
22. Engineering of an isolated p110α subunit of PI3Kα permits crystallization and provides a platform for structure-based drug design.
Chen P; Deng YL; Bergqvist S; Falk MD; Liu W; Timofeevski S; Brooun A
Protein Sci; 2014 Oct; 23(10):1332-40. PubMed ID: 25043846
[TBL] [Abstract][Full Text] [Related]
23. A new evaluation method for quantifying PI3K activity by HTRF assay.
Sugita H; Dan S; Kong D; Tomida A; Yamori T
Biochem Biophys Res Commun; 2008 Dec; 377(3):941-5. PubMed ID: 18952065
[TBL] [Abstract][Full Text] [Related]
24. Structure of the catalytic and ubiquitin-associated domains of the protein kinase MARK/Par-1.
Panneerselvam S; Marx A; Mandelkow EM; Mandelkow E
Structure; 2006 Feb; 14(2):173-83. PubMed ID: 16472737
[TBL] [Abstract][Full Text] [Related]
25. A frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membrane.
Mandelker D; Gabelli SB; Schmidt-Kittler O; Zhu J; Cheong I; Huang CH; Kinzler KW; Vogelstein B; Amzel LM
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):16996-7001. PubMed ID: 19805105
[TBL] [Abstract][Full Text] [Related]
26. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation.
Kim C; Cheng CY; Saldanha SA; Taylor SS
Cell; 2007 Sep; 130(6):1032-43. PubMed ID: 17889648
[TBL] [Abstract][Full Text] [Related]
27. Human intestinal maltase-glucoamylase: crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity.
Sim L; Quezada-Calvillo R; Sterchi EE; Nichols BL; Rose DR
J Mol Biol; 2008 Jan; 375(3):782-92. PubMed ID: 18036614
[TBL] [Abstract][Full Text] [Related]
28. Insights into the pathological mechanisms of p85α mutations using a yeast-based phosphatidylinositol 3-kinase model.
Oliver MD; Fernández-Acero T; Luna S; Rodríguez-Escudero I; Molina M; Pulido R; Cid VJ
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143957
[TBL] [Abstract][Full Text] [Related]
29. Cryo-EM structures of cancer-specific helical and kinase domain mutations of PI3Kα.
Liu X; Zhou Q; Hart JR; Xu Y; Yang S; Yang D; Vogt PK; Wang MW
Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2215621119. PubMed ID: 36343266
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of the alpha subunit of human translation initiation factor 2B.
Hiyama TB; Ito T; Imataka H; Yokoyama S
J Mol Biol; 2009 Oct; 392(4):937-51. PubMed ID: 19631657
[TBL] [Abstract][Full Text] [Related]
31. Hot-spot mutations in p110alpha of phosphatidylinositol 3-kinase (pI3K): differential interactions with the regulatory subunit p85 and with RAS.
Zhao L; Vogt PK
Cell Cycle; 2010 Feb; 9(3):596-600. PubMed ID: 20009532
[TBL] [Abstract][Full Text] [Related]
32. Calcineurin B-like domains in the large regulatory alpha/beta subunits of phosphorylase kinase.
Carrière C; Mornon JP; Venien-Bryan C; Boisset N; Callebaut I
Proteins; 2008 Jun; 71(4):1597-606. PubMed ID: 18320589
[TBL] [Abstract][Full Text] [Related]
33. The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin.
Raaf J; Klopffleisch K; Issinger OG; Niefind K
J Mol Biol; 2008 Mar; 377(1):1-8. PubMed ID: 18242640
[TBL] [Abstract][Full Text] [Related]
34. Cancer-specific mutations in phosphatidylinositol 3-kinase.
Vogt PK; Kang S; Elsliger MA; Gymnopoulos M
Trends Biochem Sci; 2007 Jul; 32(7):342-9. PubMed ID: 17561399
[TBL] [Abstract][Full Text] [Related]
35. Structural and functional studies of the yeast class II Hda1 histone deacetylase complex.
Lee JH; Maskos K; Huber R
J Mol Biol; 2009 Aug; 391(4):744-57. PubMed ID: 19573535
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the inter-SH2 domain of the regulatory subunit of phosphoinositide 3-kinase: effects on catalytic subunit binding and holoenzyme function.
Elis W; Lessmann E; Oelgeschlager M; Huber M
Biol Chem; 2006 Dec; 387(12):1567-73. PubMed ID: 17132102
[TBL] [Abstract][Full Text] [Related]
38. Impact of intra-subunit domain-domain interactions on creatine kinase activity and stability.
Zhao TJ; Feng S; Wang YL; Liu Y; Luo XC; Zhou HM; Yan YB
FEBS Lett; 2006 Jul; 580(16):3835-40. PubMed ID: 16797013
[TBL] [Abstract][Full Text] [Related]
39. Crystal structure of the GluR0 ligand-binding core from Nostoc punctiforme in complex with L-glutamate: structural dissection of the ligand interaction and subunit interface.
Lee JH; Kang GB; Lim HH; Jin KS; Kim SH; Ree M; Park CS; Kim SJ; Eom SH
J Mol Biol; 2008 Feb; 376(2):308-16. PubMed ID: 18164033
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of the regulatory subunits for phosphatidylinositol 3-kinase in response to motor nerve injury.
Okamoto T; Namikawa K; Asano T; Takaoka K; Kiyama H
Brain Res Mol Brain Res; 2004 Nov; 131(1-2):119-25. PubMed ID: 15530660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
